Summary
Major opportunities in the bioclate (Armour) market include personalized hemophilia care growth, expanding home infusion programs, and increased access in emerging markets. Rising hemophilia diagnosis rates and long-term therapy adherence also drive demand, w
Source: GlobeNewswire
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
